Similar articles

• Herb-drug interactions in oncology.

  Goey AK, Beijnen JH, Schellens JH. Goey AK, et al. Clin Pharmacol Ther. 2014 Apr;95(4):354-5. doi: 10.1038/clpt.2014.18. Clin Pharmacol Ther. 2014. PMID: 24646483 No abstract available.
• [Pharmacokinetic drug interactions between anticancer therapeutics and drugs of complementary medicine: mechanisms and clinical relevance].

  Unger M. Unger M. Forsch Komplementmed. 2011;18(4):213-8. doi: 10.1159/000330937. Epub 2011 Aug 11. Forsch Komplementmed. 2011. PMID: 21934321 Review. German. No abstract available.
• One oncologist's view of integrative care: keynote address, comprehensive cancer care conference, April 2003.

  Gaynor M. Gaynor M. Integr Cancer Ther. 2004 Mar;3(1):82-7. doi: 10.1177/1534735403262316. Integr Cancer Ther. 2004. PMID: 15035879 No abstract available.
• Herbal medicines safety concerns in patients with cancer.

  Bagcchi S. Bagcchi S. Lancet Oncol. 2016 Jan;17(1):e10. doi: 10.1016/S1470-2045(15)00563-X. Epub 2015 Dec 4. Lancet Oncol. 2016. PMID: 26670091 No abstract available.
• Complementary and alternative therapies in pediatric oncology.

  Sencer SF, Kelly KM. Sencer SF, et al. Pediatr Clin North Am. 2007 Dec;54(6):1043-60; xiii. doi: 10.1016/j.pcl.2007.10.007. Pediatr Clin North Am. 2007. PMID: 18061790 Review.